Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Canopy Growth

Market Rebound? Not for These 2 Marijuana Stocks

The terms of Aurora's new financing doesn't bode well for existing shareholders.

Why Aurora Cannabis' 39% Drop Is Leading the Marijuana Sector Down Friday

Flora Growth Corp

High Tide

Boston Beer Company

Tilray Brands

Urban-gro

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

6 Cannabis Stocks Trying to Burn the Bears This Week

Cannabis stocks are sinking today after Canopy Growth's Q4 revenue came in below analysts' average outlook. The post Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint appeared first on InvestorPlace.

Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint

Aurora Cannabis Inc. (NASDAQ: ACB) shares are trading lower after the company announced it has enetered into a bought deal financing agreement. Aurora announced today that it has amended the terms of its previously announced bought deal financing.

Why Aurora Cannabis Stock Is Getting Hammered Today

Aurora Cannabis Inc. ACB, -31.79% ACB, +1.17% shares dropped 28% Friday after the cannabis company said it would increase the size of its bought deal financing to $150 million from $125 million. A syndicate of underwriters led by Canaccord Genuity and BMO Capital Markets will buy on a bought deal basis 61.2 million units of the company at a price of $2.45 per unit for gross proceeds of approximately $150 million.

Aurora Cannabis ups financing deal to $150 mln, shares fall

NASDAQ | TSX: ACB EDMONTON, AB, May 27, 2022 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has announced today that it has amended the terms of its previously announced bought deal financing. Under the amended terms, a syndicate of underwriters led by Canaccord Genuity and BMO Capital Markets, have agreed to buy on a bought deal basis 61.2 million units of the Company (the "Units"), at a price of US$2.45 per Unit for gross proceeds of approximately US$150.0 million (the "Offering").

Aurora Cannabis Inc. Announces Upsize to Previously Announced Bought Deal Financing

It's been barely two years since Aurora Cannabis' last reverse stock split.

Is Another Reverse Stock Split Inevitable for This Once-Promising Growth Stock?

SNDL Inc.

Selling pot is apparently quite difficult to do profitably.

3 Hot Marijuana Stocks That Could Easily Turn $5,000 Into $500

Shares of Aurora Cannabis Inc. were lower in Thursday's late trading session, after the company announced $125 million of bought-deal financing.

Aurora Cannabis announces bought-deal financing, shares drop 16%

EDMONTON, AB, May 26, 2022 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity and BMO Capital Markets, under which the underwriters have agreed to buy on bought deal basis 51.1 million units of the Company (the "Units"), at a price of US$2.45 per Unit for gross proceeds of approximately US$125.2 million (the "Offering"). Each Unit will be comprised of one common share of the Company (a "Common Share") and one common share purchase warrant of the Company (a "Warrant").

Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing

Cronos Group

3 Canadian Marijuana Stocks To Watch At The End Of The Month The post Top Canadian Marijuana Stocks To Watch This June appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Watch This June

Curaleaf Holdings, Inc.

Yet another state goes legal with recreational weed.

Why Pot Stocks Like Sundial Growers and Curaleaf Were Buzzing Today

Greenlane Holdings

GrowGeneration Corp

Innovative Industrial Properties

Intercure Ltd

Incannex Healthcare Inc

Akerna Corp

Leafly Holdings

What Happened With These 11 Cannabis Stocks This Week?

Forget about a so-called perfect investment, but for contrarians, an ACB stock buy looks perfectly suitable to purchase today The post Why Aurora Cannabis Stock Is Still Worth Buying appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn't matter if you have $500 in savings or $5 million.

Why Aurora Cannabis Stock Is Still Worth Buying

OrganiGram Holdings Inc.

Are Penny Stocks On Watch In This Downtrend In May? The post Best Marijuana Penny Stocks For 2022? 3 For Reddit Investors Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Marijuana Penny Stocks For 2022? 3 For Reddit Investors Right Now

State-of-the-art facility readying first delivery of medical grade cannabis for German patients EDMONTON, AB , May 18, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the company has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany. As a leading manufacturer of medical cannabis worldwide, achieving EU-GMP certification of the company's first German manufacturing site marks a significant milestone in the fulfillment of an awarded tender by the German Federal Institute for Drugs and Medical Devices (BfArM).

Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility

Redfin

Vaxart

Select analysts foresee these once-popular stocks delivering huge gains for shareholders.

These 3 Former High-Flying Stocks Can Soar Up to 439%, According to Wall Street

SPDR S&P 500 ETF Trust

Affirm

The S&P 500 ETF, Costco, Affirm and Aurora Cannabis were our top stock trades for Monday. Now, let's have a look at the charts.

4 Top Stock Trades for Monday: SPY, COST, AFRM, ACB

Aurora just "beat" on sales -- but its losses this past quarter were mind-boggling.

Why Aurora Cannabis, Canopy, and Sundial Stocks Popped on Friday

Agrify

Clever Leaves Holdings Inc

Top Penny Stocks To Watch Right Now The post Best Cannabis Stocks To Watch On The Nasdaq For Mid May 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Cannabis Stocks To Watch On The Nasdaq For Mid May 2022

Aurora Cannabis Inc. (NASDAQ:ACB ) Q3 2022 Results Conference Call May 12, 2022 5:00 PM ET Company Participants Ananth Krishnan - Vice President, Strategic Finance Miguel Martin - Chief Executive Officer Glen Ibbott - Chief Financial Officer Conference Call Participants Michael Lavery - Piper Sandler Andrew Carter - Stifel John Zamparo - CIBC World Markets Andrew Blonde - Jefferies Frederico Gomes - ATB Matt Bottomley - Canaccord Genuity Doug Miehm - RBC Capital Markets Operator Greetings, and welcome to the Aurora Cannabis Inc Third Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.

Aurora Cannabis Inc. (ACB) CEO Miguel Martin on Q3 2022 Results - Earnings Call Transcript

Increasing Original Target for Expense Savings; Management Now Expects $150 to $170 Million in Annualized Cost Savings by H1/2023 versus Stated Target of $60 to $80 Million Reiterating Adjusted EBITDA Profitability Run Rate by the End of Fiscal H1 2023 Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Revenue Increased 55% from Q3 2021 Strong balance sheet; Early Repurchase of $141.4 Million in Convertible Debt EDMONTON, AB , May 12, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the third quarter fiscal 2022 ended March 31, 2022. "We continue to steer our differentiated global cannabis business towards long term shareholder value creation.

Aurora Cannabis Announces Fiscal 2022 Third Quarter Results

Toast

All three major U.S. indexes were in the green in Wednesday's early trading.

Earnings Previews: Affirm, Aurora Cannabis, Toast

GasLog Partners

Platinum Group Metals

Investing in penny stocks that exhibit secular growth could be just what you need to bypass a bear market. These three pennies are great value for money, grab them before somebody else does!

3 Oversold Penny Stocks to Buy Now

News for Aurora Cannabis Stock (ACB)